The intravascular contrast agent Clariscan⢠(NC 100150 injection) for 3D MR coronary angiography in patients with coronary artery disease
✍ Scribed by Klein, C
- Publisher
- Springer
- Year
- 2000
- Tongue
- English
- Weight
- 252 KB
- Volume
- 11
- Category
- Article
- ISSN
- 0968-5243
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Purpose To assess the feasibility of Clariscan™, an intravascular contrast agent, for free breathing, navigator assisted, high resolution, three‐dimensional‐magnetic resonance coronary angiography (MRCA) in patients, as extracellular contrast agents are unfavorable for the improveme
## Abstract ## Purpose To examine magnetic resonance coronary artery imaging after NC100150‐Injection. ## Materials and Methods Breath‐hold and navigator‐gated images were acquired in five patients. ## Results Breath‐hold image quality, coronary artery‐fat SDNR, and coronary artery SNR improve